{"name":"Oxford Pharmascience Ltd","slug":"oxford-pharmascience-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"OXP001","genericName":"OXP001","slug":"oxp001","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"OXP001","genericName":"OXP001","slug":"oxp001","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQRkpUd2VUVHRuWDF2VFFkeWtqSnhMVUZiX2RqNjJzZHROcWZyN0wtamZ4YTRYOVZlRTNMTjd6YldPOExnN0RlZ1J6TUt3amxIZ0pWM19RZ1E1YTNnQTRGbWRCNm9aSm9zRUhfeVBOYzVhemVSNjR1TTV6d0FUTW5GXzhuNjRaUXlvR2JFVTFJdw?oc=5","date":"2017-11-10","type":"deal","source":"Share Talk","summary":"Oxford Pharmascience Group (AIM:OXP) Announcement of demerger - Share Talk","headline":"Oxford Pharmascience Group (AIM:OXP) Announcement of demerger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNQUp6Q0EyOHRVYWhCeFJqbGVXQ29RSWdwUG9pcW52Zk9mc2hEY2pFYmhUaDRzV0V3ZGQ0dW5VM2dJYjhPZXhHTEJyVTlhVWRMNE41RFBXYTBtWmVxTnoza2JaXzVnWkNYaUNid3luSzhxanpaZHdhNng0bFZQMEhubnh5MEVRR1owLXozc2s5SDRTVTlyX1BfRHpoVzE?oc=5","date":"2017-08-09","type":"pipeline","source":"Australian Institute for Bioengineering and Nanotechnology (AIBN)","summary":"AIBN drug delivery nanotechnology ready for commercialisation - Australian Institute for Bioengineering and Nanotechnology (AIBN)","headline":"AIBN drug delivery nanotechnology ready for commercialisation - Australian Institute for Bioengineering and Nanotechnolo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOSlVIWnNLbm5sUDBJT20zU09fNkdhcnc4c2hFN29lV0xUR3JRUGtXUUlocTBTdXhvMHM4ZHUzdmNIbkxkMUFuTU92aktwclNURU5YRUZyMTBDLVB3d1BLVGt5MnhhYjFqbTFUT2ZRUzVKOTYtdEtVVGFQV0ZUN05qMFhuZ2EzSzcteUlhLVZUZ244LWk5OTBBRWQxNlcxVkFDMC0tR2djZkMxV0ZyOWMtY3M1VmNiZUla?oc=5","date":"2015-12-18","type":"pipeline","source":"pharmaceutical-journal.com","summary":"Leading the way for women in science as a pharmaceutical entrepreneur - pharmaceutical-journal.com","headline":"Leading the way for women in science as a pharmaceutical entrepreneur - pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBZa2prZ0lHaklNYXVRa0JPR3hZanF1aWJ6Q0I4bEtMTlhvcmJoOG9YYVQ5bWZiWGxuSVlkb2E3QkRHRDBfZTdpWmxsX1RKQk93M0paM2J1SXdwMGtvS1BMcTBDeWM4RjA?oc=5","date":"2012-05-11","type":"pipeline","source":"Manufacturing Chemist","summary":"A matter of taste - Manufacturing Chemist","headline":"A matter of taste","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}